Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Nov 16, 2012

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

Nersesian has been executive vice president and COO of Agilent since November 2011. In his new post, he will continue to be responsible for Agilent's Chemical Analysis, Life Sciences, Electronic Measurement, and Order Fulfillment businesses.

Definiens has named Gerald Möller to be chairman of the company's supervisory board.

Möller previously spent 23 years at Boehringer Mannheim, where he held a range of posts in Germany, the US, and Japan, including serving as president of Decentralized Diagnostics, president of Advanced Diagnostics and Biochemicals, and CEO of Boehringer Mannheim Therapeutics and of Boehringer Mannheim Group. After Boehringer Mannheim was acquired by Roche, Möller was head of global development and strategic marketing, pharmaceuticals, and a member of the executive committee at Hoffman LaRoche.

He also is chairman of the Foundation for Innovative New Diagnostics, is chairman of the board at Morphosys, and sits on boards at Illumina, Bionostics, and Vivacta.

The California Healthcare Institute has elected five new board members, including Alan Malus and Alberto Mas.

Malus is executive VP of Thermo Fisher Scientific and president of the company's analytical technologies group. He is responsible for innovation in the company's analytical technologies, chemical analysis, environmental and process instruments, and biosciences businesses.

Mas runs Becton Dickinson's Biosciences segment, and he formerly spent six years as president of BD Medical – Medical Surgical Systems.

Also elected to CHI's board are Michael Friedman, CEO of City of Hope; Heather Mason, senior vice president of Abbott Diabetes Care; and Grant Yonehiro, president of Perseid Therapeutics.

The Edith Sanford Breast Cancer Foundation has hired Scooter Willis to serve as the director of computational bioinformatics for its bioinformatics program.

Willis is a specialist in computer science and engineering and brings expertise in the genomic analysis of expression data. In his new role, he will work alongside researchers from the Scripps Research Institute as part of a partnership between Edith Sanford and TSRI focused on personalized breast cancer treatment and care.

GenapSys has expanded its management team and scientific advisory board.

Hamid Rategh has been appointed to vice president of engineering, leading the development of the company's sequencing technology. Previously, he was senior director of engineering at Inphi, senior director of engineering at Scientera Networks, and cofounder and vice president of Engineering of Tavanza, which was acquired by Celeritek and later Anadigics.

Mirna Jarosz is director of sequencing chemistry and molecular biology. Most recently, she led the molecular biology and sequencing group at Foundation Medicine. Previously, she was manager of sequencing development at Helicos BioSciences.

Leila Rastegar is director of business development and strategy. Previously, she was a consultant at Bain & Company. She also worked in Argentina with the Endeavor network, a non-profit that supports entrepreneurs in developing countries.

Ali Mani has been appointed to Genapsys' scientific advisory board. He is an assistant professor at the Flow Physics and Computation division in the mechanical engineering department at Stanford University, where he works on fluid mechanics.

Great Basin said that it has hired Lisa Weingartner as regional business manager for the southeast US region and Richard Corbiel as applications specialist.

Weingartner joins Great Basin from Lineagen, where she held the position of regional business director. Prior to that, she worked for Genoptix, Athena Diagnostics, Specialty Labs, and Myriad Genetics.

Corbiel joins Great Basin from BD Diagnostics, where he managed that company's team of molecular client consultants. Prior to BD, Corbiel held similar positions at GeneOhm Sciences (now part of BD), BioMérieux, and Gen-Probe (now part of Hologic).

Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.